CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (Chinese version)

Kenneth F. Schulz, Douglas G. Altman, David Moher, Virginia Barbour, Jesse A. Berlin, Isabelle Boutron, P. J. Devereaux, Kay Dickersin, Diana Elbourne, Susan Ellenberg, Val Gebski, Steven Goodman, Peter C. Gøtzsche, Trish Groves, Steven Grunberg, Brian Haynes, Sally Hopewell, Astrid James, Peter Juhn, Philippa MiddletonDon Minckler, Victor M. Montori, Cynthia Mulrow, Stuart Pocock, Drummond Rennie, David L. Schriger, Iveta Simera, Elizabeth Wager, Mike Clarke, Gordon Guyatt

Producción científica: Articlerevisión exhaustiva

153 Citas (Scopus)

Resumen

The CONSORT statement is used worldwide to improve the reporting of randomised controlled trials. Kenneth Schulz and colleagues describe the latest version, CONSORT 2010, which updates the reporting guideline based on new methodological evidence and accumulating experience. To encourage dissemination of the CONSORT 2010 Statement, this article is freely accessible on bmj.com and will also be published in the Lancet, Obstetrics and Gynecology, PLoS Medicine, Annals of Internal Medicine, Open Medicine, Journal of Clinical Epidemiology, BMC Medicine, and Trials.

Idioma originalEnglish (US)
Páginas (desde-hasta)604-612
Número de páginas9
PublicaciónJournal of integrative medicine
Volumen8
N.º7
DOI
EstadoPublished - jul 2010
Publicado de forma externa

ASJC Scopus subject areas

  • Complementary and alternative medicine

Huella

Profundice en los temas de investigación de 'CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (Chinese version)'. En conjunto forman una huella única.

Citar esto